Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer

By de Lange S.M.   van Groeningen C.J.   Meijer O.W.M.   Cuesta M.A.   Langendijk J.A.   van Riel J.M.G.H.   Pinedo H.M.   Peters G.J.   Meijer S.   Slotman B.J.   Giaccone G.  

European Journal of Cancer, Vol. 38, Iss. 9, 2002-06 ,pp. : 1212-1217

Elsevier

Access to resources Recommend Favorite

Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer

By Song Hunho   Han Boram   Park Choong   Kim Jong   Jeon Jang   Kim In-Gyu   Kim Hyo   Jung Joo   Kim Jung   Kwon Jung   Jang Geundoo   Kim Ho   Kim Hyeong   Choi Dae   Zang Dae  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 4, 2013-10 ,pp. : 845-852

Springer Publishing Company

Access to resources Recommend Favorite

Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1)

By Massaccesi Mariangela   Ferro Marica   Cilla Savino   Balducci Mario   Deodato Francesco   Macchia Gabriella   Valentini Vincenzo   Morganti Alessio  

International Journal of Clinical Oncology, Vol. 18, Iss. 5, 2013-10 ,pp. : 784-791

Springer Publishing Company

Access to resources Recommend Favorite

Comparing dose-volume histogram and radiobiological endpoints for ranking intensity-modulated arc therapy and 3D-radiotherapy treatment plans for locally-advanced pancreatic cancer

By Warren Samantha   Partridge Mike   Fokas Emmanouil   Eccles Cynthia L.   Brunner Thomas B.  

Acta Oncologica, Vol. 52, Iss. 7, 2013-10 ,pp. : 1573-1578

Informa Healthcare

Access to resources Recommend Favorite

Intensity-modulated radiotherapy for the treatment of pelvic lymph nodes in prostate cancer

By Guckenberger Matthias   Flentje Michael  

Future Oncology, Vol. 3, Iss. 1, 2007-02 ,pp. : 43-47

Future Medicine

Access to resources Recommend Favorite